As you are aware the EU Clinical Trials Directive has become part of the UK's regulatory and legal landscape from 1 May, 2004. Richmond Pharmacology has welcomed the directive which will help to harmonise trial standards across the board.We support the MHRA (Medicines and Healthcare products Regulatory Agency) which regulates implementation of the Directive, and we applaud our industry partners who have ensured that the implementation does not slow down or hinder the competitiveness of the UK's clinical research industry.This guide has been put together following numerous client requests for more information and greater clarity on how the directive will impact on research projects, timelines and approval systems.Direction on the Directive